Deutsche Bank lowers its price target on Hold-rated Humana HUM from $93 to $85 on significant margin contraction seen in the company's Q1 Medicare segment.
Deutsche Bank comments, "Core Retail (Medicare) segment shows significant margin contraction in 1Q12. Humana's 1Q12 EPS slumped by 20% from 1Q11 as significant margin contraction in the core Retail segment more than offset solid 11% revenue growth. While HUM raised 2012 EPS guidance by a nickel, it trimmed Retail segment margin guidance for the second time this year. Investors had been expecting margin upside in the Retail segment to drive EPS beats during 2012. We reduce 2012-2013 EPS ests & PT. Maintain Hold rating with solid MA growth offset by margin pressures."
HUM closed at $80.68 on Monday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in